Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Dec;56(6):1092-1095.
doi: 10.1002/mus.25600. Epub 2017 Apr 29.

Charcot-Marie-Tooth disease type 1C: Clinical and electrophysiological findings for the c.334G>a (p.Gly112Ser) Litaf/Simple mutation

Nivedita U Jerath  1 , Michael E Shy  1
Affiliations

Charcot-Marie-Tooth disease type 1C: Clinical and electrophysiological findings for the c.334G>a (p.Gly112Ser) Litaf/Simple mutation

Nivedita U Jerath et al. Muscle Nerve. 2017 Dec.

Abstract

Introduction: Charcot-Marie-Tooth disease type 1C (CMT1C) is a rare, dominantly inherited neuropathy caused by mutations in the lipopolysaccharide-induced tumor necrosis factor (LITAF) or small integral membrane protein of the lysosome/late endosome (SIMPLE) gene.

Methods: We present a case series comprised of 10 patients in whom CMT1C is caused by a Gly112Ser substitution in the encoded protein. We focus on clinical presentation, electrodiagnostic analyses, and our findings in the context of previously described cases.

Results: The Gly112Ser mutation causing CMT1C is a mild form of CMT, as patients walked on time, had less weakness than those with Charcot-Marie-Tooth disease type 1A (CMT1A), had a CMT neuropathy score (CMTNS) indicative of mild disease, and had faster ulnar and median motor nerve conduction velocities compared to those with CMT1A.

Discussion: The G112S mutation in LITAF seems to be clinically indistinguishable from a mild presentation of CMT1A. Muscle Nerve 56: 1092-1095, 2017.

Keywords: CMT1C; EDx; HMSN type 1; LITAF; SIMPLE; nerve conduction studies.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Clinical signs. Comparison of CMT1C Gly112Ser mutation with CMT1A. Histogram shows percent of clinical signs in patients with CMT1C (n = 9) and CMT1A (n = 119).[17]
See this image and copyright information in PMC

References

    1. Potulska-Chromik A, Sinkiewicz-Darol E, Kostera-Pruszczyk A, Drac H, Kabzinska D, Zakrzewska-Pniewska B, et al. Charcot-Marie-Tooth type 1C disease coexisting with progressive multiple sclerosis: a study of an overlapping syndrome. Folia Neuropathol. 2012;50:369–374. - PubMed
    1. Gerding WM, Koetting J, Epplen JT, Neusch C. Hereditary motor and sensory neuropathy caused by a novel mutation in LITAF. Neuromuscul Disord. 2009;19:701–703. - PubMed
    1. Street VA, Bennett CL, Goldy JD, Shirk AJ, Kleopa KA, Tempel BL, et al. Mutation of a putative protein degradation gene LITAF/SIMPLE in Charcot-Marie-Tooth disease 1C. Neurology. 2003;60:22–26. - PubMed
    1. Latour P, Gonnaud PM, Ollagnon E, Chan V, Perelman S, Stojkovic T, et al. SIMPLE mutation analysis in dominant demyelinating Charcot-Marie-Tooth disease: three novel mutations. J Periph Nerv Syst. 2006;11:148–155. - PubMed
    1. Luigetti M, Fabrizi GM, Taioli F, Del Grande A, Lo Monaco M. A novel LITAF/SIMPLE variant within a family with minimal demyelinating Charcot-Marie-Tooth disease. Neurol Sci. 2014;35:2005–2007. - PubMed

Supplementary concepts